Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
2 hedge funds and large institutions have $101K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
9.27% less ownership
Funds ownership: 10.31% → 1.04% (-9.3%)
67% less funds holding
Funds holding: 6 → 2 (-4)
93% less capital invested
Capital invested by funds: $1.45M → $101K (-$1.35M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$37.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$717K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$337K |
| 3 |
Goldman Sachs
New York
|
-$196K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$120K |
PILL Hedge Fund Activity: Q3 2022 in Review
2 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q3 2022, worth a combined $101K — down 93% from $1.45M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PILL and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $37.5K. The largest seller was Old Mission Capital, exiting entirely with an estimated $717K sold.
- 2 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q3 2022, down from 6 in Q2 2022.
- Funds reported $101K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q3 2022, down 93% quarter-over-quarter.
- 0 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q3 2022 and 4 closed out, a net change of -4 holders.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q3 2022 was UBS Group, an estimated $37.5K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q3 2022 was Old Mission Capital, an estimated $717K sold.
Based on aggregated 13F filings for Q3 2022.